ISoOR Insight Team. (2026). Genmab Acquires Merus for $8 Billion: The First Organoid-Discovered Clinical Asset Drives the Largest European Oncology Deal of 2025. Journal of Organoid and Bioscience, 3(1). Retrieved from https://jobs.isoor.org/index.php/journal/article/view/57